![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/661 | |
A61K 31/685 | |||
A61K 31/56 | |||
A61K 9/08 | |||
A61P 27/02 |
(11) | Number of the document | 2797601 |
(13) | Kind of document | T |
(96) | European patent application number | 13747021.7 |
Date of filing the European patent application | 2013-02-08 | |
(97) | Date of publication of the European application | 2014-11-05 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/025390 |
Date | 2013-02-08 |
(87) | Number | WO 2013/119988 |
Date | 2013-08-15 |
(30) | Number | Date | Country code |
201261597189 P | 2012-02-10 | US |
(72) |
HONG, Keelung, US
GUO, Luke S.S., US
TSENG, Yun-Long, TW
SHIH, Sheue-Fang, TW
CHANG, Po-Chun, TW
TSAI, Chih-Chiang, TW
LIN, Hong-Hui, TW
|
(73) |
Taiwan Liposome Company, Ltd.,
11F-1 No 3 Yuanqu Street Nangang District, Taipei City,
TW
TLC Biopharmaceuticals, Inc., 432 North Canal Street 20, South San Francisco, CA 94080, US |
(54) | PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID |
PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID |